HLE Glascoat Ltd Q4 FY2025 Concall Summary

Key Takeaways

• Milestone quarter, margin recovery: EBITDA hit Rs. 54 crores at a 16.3% margin after several soft quarters, driven by operating leverage from existing operations.
• Pharma drove the mix shift: Pharma surged to 66% of Q4 revenue from 45% in Q3, while the chemical segment showed an encouraging uptick in inquiries and order book.
• F&D revenue lagged bookings: A late surge in F&D order booking could not convert to revenue within the quarter due to a 16-week cycle time, setting up a top-line recovery this year.
• Balance sheet strengthened: Strong cash generation enabled roughly Rs. 50 crores of debt reduction, with working capital rationalization and further deleveraging remaining key priorities.
• What to watch next quarter: Whether the F&D order backlog converts to revenue as guided, the pace of the chemical sector recovery beyond pharma, and the final NCLT hearing on the Kinam amalgamation in July 2025.

Pharma Surge & Sector Mix

• Pharma share jumped: Q4 revenue from pharma reached 66%, up sharply from 45% in Q3, reflecting a very positive uplift in Indian pharma investment and fresh capacity creation.
• Chemical segment stirring: Agrochemicals, basic chemicals, dyes, colorants and pigments have seen encouraging development but not at the expected level; a full growth opportunity awaits sector revival.
• Mix parity the goal: Management expects other industry segments to pick up going forward while pharma remains strong, aiming for relative parity between pharma and the rest of the chemical business.
• Segment margins similar: Margins are broadly similar across pharma, chemical and other segments, so the mix shift does not mechanically drag or lift blended profitability.
• Replacement demand is expansionary: Even replacement orders typically involve customers upsizing equipment, so they represent additional investment rather than mere maintenance.

Harsh Patel: "Quarter 4, 2025 reflects what is possible when strategic clarity meets disciplined execution. As India's process industries surge ahead, we at HLE Glascoat are well positioned to play a meaningful role in enabling their successes."

Filtration & Drying: The Revenue Lag

• Order book surged late: F&D order booking was subdued in the first two quarters, picked up in the last two, and was concentrated predominantly in Q4.
• Cycle time blocked revenue recognition: With a roughly 16-week cycle time, many Q4-booked orders could not be dispatched within the quarter, and revenue is recognized only on dispatch.
• High visibility into recovery: The order book gives over six months of visibility, so management expects F&D top line to recover this year.
• Sustainable margin target intact: Management still believes the long-term sustainable margin for both GLE and F&D businesses in India is in the 17% to 18% range.

Aalap Patel: "we still believe that a long-term sustainable margin for the India business is in the 17% to 18% range, and that for the German business is in the 14% to 15% range."

Kinam Engineering & Diversification

• First large oil & gas order shipped: Kinam Engineering initiated supplies of its first large oil and gas order, to be fully executed in Q1 FY26, marking a strategic entry into a high-potential vertical.
• Track record unlocks pipeline: The order, supplied to a large public-private joint venture, establishes critical track record that management expects will pave the way for further orders.
• NCLT hearing in July 2025: The final hearing for approval of the scheme of amalgamation of Kinam Enterprise Private Limited with HLE Glascoat is scheduled for July 2025; once approved, HLE will own a 70% stake in Kinam Engineering Industries.
• Kinam FY26 target: Management expects Kinam to cross Rs. 200 crores in FY26.
• Oil & gas PSU outreach underway: Management is in touch with PSU giants including ONGC, HPCL and BPCL.

Nilesh Ganjwala: "This will pave the way for further orders because this establishes the track record, which is very critical in this industry."

Thaletec & International Business

• Thaletec margin improved considerably: Margins improved to close to about 15% at the EBITDA level over the last year.
• Guidance for FY26: Thaletec growth estimated at around 15% for the coming year, with EBITDA margin in the 14% to 15% range.
• European tailwind from trade shifts: European countries are investing in segments previously going to Asia due to trade wars with China and the Ukraine/Russia situation; management sees a long-term trend of more investment coming to Thaletec's glass-lined business in Europe.
• U.S. tariff advantage: U.S. tariffs are creating a 10% to 20% differential advantageous for India for the U.S. market.
• International order book visibility: Healthy order book with business visibility of over 7 months for the international business, versus over 6 months for India.

Competitive Position & Market Share

• Market share gains: Strong focus on customer engagement, new value-added products, introducing Thaletec technologies in India, and continuous improvement on quality and price has helped gain market share over the last two to three quarters.
• Full-suite differentiation: HLE offers glass-lined, filtration-drying, and mixing solutions under one roof, positioning itself as a solution provider while most competitors offer a singular product.
• Center of Excellence inaugurated: A state-of-the-art R&D and production facility for glass lining at Anand will support fundamental research, new product development, and rapid prototyping for Thaletec, with a long-term objective of opening doors to entirely new industries in the material space.
• No large CAPEX planned: Only minimal, maintenance-level CAPEX is lined up for this year.

Aalap Patel: "There is no competitor in India which has all of these platforms available under any one single roof. So to that extent, what we offer is a solution, whereas most of our competition basically offer a singular product."

Balance Sheet & Capital Allocation

• Rs. 50 crores debt reduced: Strong cash generation enabled reduction of both long-term and short-term debt obligations by approximately Rs. 50 crores.
• Working capital and deleveraging remain priorities: Rationalizing the working capital cycle and further debt reduction will stay key priorities, backed by consistent growth, sustained cash flow and prudent capital allocation.
• Receivables collection improved significantly: The improvement in FY25 is expected to continue in the coming year.
• Dividend held flat: The board proposed continuing with the same dividend of 55% as declared last year to conserve resources for the growth plan.
• Renewable energy JV: A captive renewable energy platform with Clean Max Group (HLE stake: 26%) will replace current grid-purchased energy at Anand, with the advantage reflected in lower energy costs going forward.
• Promoter share purchase: Directors purchased about 60,500 shares from the market on March 28th and 29th as a show of confidence.

Guidance & Commitments

Key Metrics